SJT Molecular Research
New family of molecules with oral therapeutic potential in obesity, hepatic steatosis, NASH, hypertension, dyslipidemia and type 2 diabetes.
SJT Molecular Research operates in biotechnology based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2015.
The company sits in the biotechnology segment, where it competes on its core product or service.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Private company stage.
| Sector | Biotechnology |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2015 |
| Stage | Private company |
Website: www.sjtmolecular.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account